CASTELLI JEFF (Chief Development Officer) sold 14.8% of their position (76.16K shares) of AMICUS THERAPEUTICS, INC. on the open market
Open‑market sale worth $773.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/26/2025ACC: 0001193125-25-301021
Officer· Chief Development Officer
Since Dec 2022
-76.16K
Net shares
Net seller
$773.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
50K acquired · 126.16K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+50K
Price / share
$9.03
Trade value
$451.50K
% of position
10.7%
11/24/2025
465.48K→515.48K
Common Stock
Direct
Shares
−76.16K
Price / share
$10.16
Trade value
$773.66K
% of position
14.8%
11/24/2025
515.48K→439.32K
Total
Net shares
−26.16K
Net value
-$322.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/24/2025 | M · Option Exercise | +50K | $9.03 | $451.50K | 10.7% | 465.48K | 515.48K |
| Common Stock Direct | 11/24/2025 | S · Sale | −76.16K | $10.16 | $773.66K | 14.8% | 515.48K | 439.32K |
| Total | −26.16K | -$322.16K | ||||||
Derivative Transactions1
Stock Options (right to buy)
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
9.03
Held after
0.00
Exercisable
—
11/24/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) Direct | Common Stock50K shares | 11/24/2025 | M · Option Exercise | −50K | 9.03 | — | 0.00 |